Qiagen

Yahoo Finance • 8 days ago

Bruker Announces Appointment of Thierry Bernard to its Board of Directors

Thierry Bernard BILLERICA, Mass., April 01, 2026--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announces the appointment of Mr. Thierry L. Bernard to serve on its Board of Directors, effective as of today. Mr. Bernard is an internat... Full story

Yahoo Finance • 20 days ago

Liquid Biopsy Products Market Report 2026-2031 Featuring Analysis of Roche, Illumina, Qiagen, MDxHealth, Novogen, BGI, Myriad Genetics and More

Company Logo Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Product Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering. The global liquid biopsy product m... Full story

Yahoo Finance • last month

Qiagen CEO says working with advisers on strategic review

[Qiagen Markets QIAstat-Dx For Coronavirus Testing] Sascha Schuermann/Getty Images News Qiagen NV (QGEN [https://seekingalpha.com/symbol/QGEN]) CEO Thierry Bernard said the company is working with Moelis & Co. and Goldman Sachs to review... Full story

Yahoo Finance • last month

Immunoassay for Neurological Biomarkers Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

Company Logo The market for immunoassays targeting neurological biomarkers is driven by the global rise in neurological disorders, increasing demand for early diagnostics, AI integration enhancing biomarker detection, and personalized the... Full story

Yahoo Finance • last month

Personalized Medicine Market Competitive Landscape Report 2025: Company Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo Personalized Medicine Market Poised for Tremendous Growth by 2033The global personalized medicine market, valued at approximately US$ 585.53 billion in 2026, is projected to soar to nearly US$ 1.00 trillion by 2033. A report... Full story

Yahoo Finance • last month

Cancer Diagnostics Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts" report has been added to Rese... Full story

Yahoo Finance • 2 months ago

Qiagen targets 9% growth in 2026 growth pillars and $2B by 2028 with new product launches

Earnings Call Insights: Qiagen N.V. (QGEN) Q4 2025 MANAGEMENT VIEW * Thierry Bernard, CEO, stated that "QIAGEN continued to perform and delivered a solid finish to '25 with results in the fourth quarter, again above outlook." Bernard h... Full story

Yahoo Finance • 2 months ago

Qiagen Non-GAAP EPS of $0.62 in-line, revenue of $540M beats by $11.51M

* Qiagen press release [https://seekingalpha.com/pr/20388557-qiagen-exceeds-q4-2025-outlook-driven-by-growth-pillars] (QGEN [https://seekingalpha.com/symbol/QGEN]): Q4 Non-GAAP EPS of $0.62 in-line. * Revenue of $540M (+3.6% Y/Y) beats... Full story

Yahoo Finance • 5 months ago

Oracle Names Stephen Rusckowski to the Board of Directors

AUSTIN, Texas, Nov. 20, 2025 /PRNewswire/ -- Oracle Corporation (NYSE: ORCL) today announced that it unanimously elected Stephen Rusckowski to Oracle's Board of Directors and increased the size of the Board to 14. The election is effective... Full story

Yahoo Finance • 5 months ago

Qiagen NV Q3 25 Earnings Conference Call At 9:30 AM ET

(RTTNews) - Qiagen NV (QGENF) will host a conference call at 9:30 AM ET on November 5, 2025, to discuss Q3 25 earnings results. To access the live webcast, log on to https://event.webcasts.com/starthere.jsp?ei=1709559&tp_key=263df2a108 T... Full story

Yahoo Finance • 5 months ago

QGEN Crosses Below Key Moving Average Level

In trading on Tuesday, shares of Qiagen NV (Symbol: QGEN) crossed below their 200 day moving average of $44.79, changing hands as low as $43.26 per share. Qiagen NV shares are currently trading off about 3% on the day. The chart below sh... Full story

Yahoo Finance • 5 months ago

Qiagen Non-GAAP EPS of $0.61 beats by $0.02, revenue of $533M beats by $7.09M

* Qiagen press release [https://seekingalpha.com/pr/20292837-qiagen-exceeds-q3-2025-outlook-raises-fy-2025-adj-eps-target-announces-parse-acquisition-and] (QGEN [https://seekingalpha.com/symbol/QGEN]): Q3 Non-GAAP EPS of $0.61 beats by $... Full story

Yahoo Finance • 5 months ago

IWB's Underlying Holdings Could Mean 11% Gain Potential

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • 6 months ago

Sizing Up Qiagen Shares in 2025 After Recent Earnings Momentum

If you are weighing whether to hold, buy, or avoid Qiagen stock right now, you are not alone. It is one of those companies that keeps popping up on value investors' screens, and for good reason. The last twelve months have brought about a... Full story

Yahoo Finance • 6 months ago

WisdomTree Emerging Markets ex-State-Owned Enterprises Fund declares quarterly distribution of $0.1950

* WisdomTree Emerging Markets ex-State-Owned Enterprises Fund (XSOE [https://seekingalpha.com/symbol/XSOE]) - $0.1950 [https://www.wisdomtree.com/etfs/equity/xsoe]. * 30-Day SEC Yield of 1.37% as of Sept. 24. * Payable Sep 29; for sh... Full story

Yahoo Finance • 7 months ago

Biobanking Market Analysis and Forecast Report 2025-2035: Ethical and Legal Challenges in Biobanking - Navigating Consent and Privacy

Company Logo Driven by demand for personalized medicine and rising chronic diseases, the biobanking market faces ethical and regulatory challenges. Major players include Becton, Dickinson and Company, QIAGEN N.V., and Merck KGaA. Trends l... Full story

Yahoo Finance • 7 months ago

Qiagen N.V. (QGEN) Launches QIAseq xHYB Panels for Long-Read Sequencing

In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. Qiagen N.V. is placed seventh among them. Qiagen N.V. (NYSE:QGEN), a global leader in molecular diagnostics and sample preparation technologies, co... Full story

Yahoo Finance • 7 months ago

Asia-Pacific Non-Invasive Prenatal Testing Market Growth and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen

Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The... Full story

Yahoo Finance • 7 months ago

QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds

VENLO, Netherlands, August 28, 2025--(BUSINESS WIRE)--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION O... Full story

Yahoo Finance • 7 months ago

Qiagen to raise $750M via non-U.S. offering of convertible bonds

* Qiagen (NYSE:QGEN [https://seekingalpha.com/symbol/QGEN]) board resolved the issue of senior, unsecured net share settled convertible bonds, which may be converted in part into ordinary shares. * The company intends to issue [https:/... Full story